Considering AVS shares many other risk factors with atherosclerosis, participants with CAD may also already have established subclinical AVS, at which stage increased apoB/apoA‐I may not confer any additional risk for AVS incidence. The gene discussed is APOB; the disease is coronary artery disorder.